These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17714470)

  • 21. [Precursors to pancreatic cancer].
    Søreide K; Immervoll H; Molven A
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
    Mozzetti S; Ferlini C; Concolino P; Filippetti F; Raspaglio G; Prislei S; Gallo D; Martinelli E; Ranelletti FO; Ferrandina G; Scambia G
    Clin Cancer Res; 2005 Jan; 11(1):298-305. PubMed ID: 15671559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absence of class III β-tubulin is predictive of a favorable response to nab-paclitaxel and gemcitabine in patients with unresectable pancreatic ductal adenocarcinoma.
    Kato A; Naiki-Ito A; Naitoh I; Hayashi K; Nakazawa T; Shimizu S; Nishi Y; Okumura F; Inoue T; Takada H; Kondo H; Yoshida M; Takahashi S; Joh T
    Hum Pathol; 2018 Apr; 74():92-98. PubMed ID: 29339176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic intraepithelial neoplasia revisited and updated.
    Sipos B; Frank S; Gress T; Hahn S; Klöppel G
    Pancreatology; 2009; 9(1-2):45-54. PubMed ID: 19077454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin confers paclitaxel resistance in cervical cancer.
    Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
    Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia.
    Al-Aynati MM; Radulovich N; Riddell RH; Tsao MS
    Clin Cancer Res; 2004 Feb; 10(4):1235-40. PubMed ID: 14977820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
    Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
    J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
    Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
    Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.
    Henke RT; Haddad BR; Kim SE; Rone JD; Mani A; Jessup JM; Wellstein A; Maitra A; Riegel AT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6134-42. PubMed ID: 15448000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells.
    Neesse A; Gangeswaran R; Luettges J; Feakins R; Weeks ME; Lemoine NR; Crnogorac-Jurcevic T
    Oncogene; 2007 Mar; 26(11):1533-45. PubMed ID: 16983343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
    Maitra A; Ashfaq R; Gunn CR; Rahman A; Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2002 Aug; 118(2):194-201. PubMed ID: 12162677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis.
    Rebours V; Lévy P; Mosnier JF; Scoazec JY; Soubeyrand MS; Fléjou JF; Turlin B; Hammel P; Ruszniewski P; Bedossa P; Couvelard A
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):206-12. PubMed ID: 19765677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer.
    Esposito I; Kleeff J; Abiatari I; Shi X; Giese N; Bergmann F; Roth W; Friess H; Schirmacher P
    J Clin Pathol; 2007 Aug; 60(8):885-95. PubMed ID: 16775116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions.
    Buchholz M; Braun M; Heidenblut A; Kestler HA; Klöppel G; Schmiegel W; Hahn SA; Lüttges J; Gress TM
    Oncogene; 2005 Oct; 24(44):6626-36. PubMed ID: 16103885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
    Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.